Definitive Contract 75D30124C19752

<p>This is a $149,726.52 firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh office, a civilian federal agency, to Intact Genomics Inc., a minority-owned for-profit business, for critical functions. The contract has a period of performance through February 28, 2017 and is designated as a Total Small Business set-aside. No additional details about larger contract vehicles or subcontractors are provided.</p>

This is a $9,374,751 definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency within the Department of Health and Human Services, to Sherlock Biosciences, Inc., a for-profit company specializing in rapid, field-deployable molecular diagnostics based on CRISPR technology. The contract is for the development of a low-cost, point-of-need molecular test for influenza A and B that can utilize self-collected swab specimens. This contract...

This $243,500 firm-fixed-price purchase order was awarded to Instadiagnostics Inc., a minority-owned, for-profit small business, by the Centers for Disease Control and Prevention (CDC) under the Small Business Innovation Research (SBIR) program. The contract is for the development of rapid diagnostic tests and devices related to SBIR Topic 37. Instadiagnostics Inc. has previously received federal grants from the CDC, Department of Defense, and National Institutes of Health for the development of...

This is a SBIR Phase I contract award to Cytoimage Inc., a woman-owned small business, by the Centers for Disease Control and Prevention (CDC) of the Department of Health and Human Services (HHS). The award is for $149,531.00 and is a firm fixed price contract. The contract does not have a set-aside designation. The period of performance is from September 12, 2017 to March 11, 2018, with work to be performed in Atlanta, Georgia. The SBIR (Small Business Innovation Research) program is a...

This is a firm fixed price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract, valued at $223,532.40, is for the maintenance and services of Illumina sequencing instruments. The contract has an ultimate completion date of April 4, 2025 and does not utilize any set-aside designations. Illumina, headquartered in San Diego, California, is a...

This is a $116,371.20 firm-fixed-price purchase order contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Copial Business Strategists, LLC, an 8(a) certified small disadvantaged business. The contract is for laboratory technician services in support of the CDC's National Center for Emerging and Zoonotic Infectious Diseases (NCEZID) program. Copial Business Strategists, a minority-owned and woman-owned small business, holds...

This is a $717,999.84 cost plus fixed fee contract awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Qoolabs Inc., a self-certified small disadvantaged, woman-owned business. The contract was awarded under the Small Business Innovation Research (SBIR) Phase II program, which provides funding to small businesses for the research and development of innovative technologies. Under this contract, Qoolabs Inc. will conduct research and development...

The Centers for Disease Control and Prevention (CDC) awarded a $7,303.60 firm fixed price purchase order to Illumina, Inc. to provide supplies in support of the agency's programs. The contract has a period of performance from August 14, 2023 through September 10, 2023 and will be performed in San Diego, California. As the prime contractor, Illumina will deliver supplies to the CDC's Pittsburgh location. No major subcontractors or set aside designations were identified. The funding supports the...

This is a firm fixed-price contract awarded by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The contract is for the maintenance of sequencers, with a potential value of $142,849.88. The place of performance is Atlanta, Georgia. Illumina has previously received prime federal contracts from agencies such as the National Institutes of Health (NIH), USDA, and VA...

<p>This is a $299,999.00 Firm Fixed Price contract awarded by the National Cancer Institute, a civilian agency, to Innogenomics Technologies, L.L.C., a minority-owned small business, under the Small Business Innovation Research (SBIR) Program Phase I. The contract is for research and development in the area of biomedical (basic research). It was awarded on September 22, 2015 with a final completion date of March 21, 2017. The contract has a total small business set-aside designation.</p>